GNC_DMD_IBRO_PR_BW_F1

Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.

Safety, Fibrosis control and increased muscle strength reported clinically. TOKYO--(BUSINESS WIRE)--#duchenne--Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress...

DK-Crown-Holdings-Inc-

DraftKings Delivers Positive Adjusted EBITDA in Second Quarter; Reports Revenue of $875 Million; Raises 2023 Revenue Guidance Midpoint by $315 Million to $3.5 Billion and Improves 2023 Adjusted EBITDA Guidance Midpoint by $110 Million to ($205) Million